Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
55,68 USD | +1,72 % | -1,50 % | -18,50 % |
Resumen de negocios
Número de empleados: 497
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
T-Cell Receptors Bispecific Immunotherapies
100,0
%
| 177 | 100,0 % | 310 | 100,0 % | +75,12 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
72,4
%
| 132 | 74,7 % | 224 | 72,4 % | +69,62 % |
Europe
27,1
%
| 44 | 24,7 % | 84 | 27,1 % | +92,30 % |
International
0,5
%
| 1 | 0,6 % | 2 | 0,5 % | +52,47 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Bahija Jallal
CEO | Chief Executive Officer | 62 | 01/01/19 |
Brian DiDonato
DFI | Director of Finance/CFO | 57 | 01/04/20 |
John Trainer
COO | Chief Operating Officer | 50 | 01/10/23 |
Mohammed Dar
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/19 |
David Berman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Lily Hepworth
LAW | General Counsel | - | 01/09/18 |
Ralph Torbay
PRN | Corporate Officer/Principal | - | 16/02/21 |
Tina St. Leger
HRO | Human Resources Officer | 56 | 03/02/22 |
John Goll
AUD | Comptroller/Controller/Auditor | - | 01/08/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Perez
BRD | Director/Board Member | 59 | 01/09/19 |
John Bell
CHM | Chairman | 71 | 01/03/15 |
Bahija Jallal
CEO | Chief Executive Officer | 62 | 01/01/19 |
Peter Ratcliffe
BRD | Director/Board Member | 69 | - |
Director/Board Member | 64 | 01/11/17 | |
Roy Herbst
BRD | Director/Board Member | 60 | 28/01/21 |
Travis Coy
BRD | Director/Board Member | - | 01/09/19 |
Siddharth Kaul
BRD | Director/Board Member | - | 08/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 1 714 650 | 0 | 0 | 44,81 % |
Acción B | 1 | 48 010 999 | 44 126 909 ( 91,91 %) | 0 | |
Acción C | 1 | 48 756 022 | 0 | 0 |
Información de la empresa
Immunocore Holdings Plc
92 Park Drive Milton Park
OX14 4RY, Abingdon
+44 12 3543 8600
http://www.immunocore.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-18,50 % | 2762,76 M | |
-1,42 % | 41,35 mil M | |
+42,15 % | 40,38 mil M | |
+1,97 % | 39,05 mil M | |
-14,19 % | 26,67 mil M | |
+1,82 % | 24,07 mil M | |
-24,55 % | 18,36 mil M | |
-4,07 % | 11,68 mil M | |
+21,36 % | 11,6 mil M | |
+8,20 % | 11,15 mil M |
- Bolsa de valores
- Acciones
- Acción IMCR
- Empresa Immunocore Holdings plc